Skip to content
Riskpilot
← Back to search
Sign in
Get full access
FRESENIUS KABI NORGE AS
AS
Active
Org 980250008
Innspurten 9, 0663
Oslo
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1998
28 employees
Watchlist
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
FRESENIUS KABI NORGE AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AB
Anna Birgitta Ekwall
Chief Executive Officer
Chief Executive Officer
2025
Former (8)
TM
Tomasz Moys
Chief Executive Officer
Chief Executive Officer
2021 – 2023
TA
Tore Andreas Brevig
Deputy Member
Deputy Member
2023 – 2024
MH
Matthias Heinz Oswald
Chief Executive Officer
Chief Executive Officer
2020 – 2021
IS
Ine Synøve Stangebråten
Deputy Member
Deputy Member
2023 – 2023
BT
Björn Tommy Erlandsson
Deputy Member
Deputy Member
2023 – 2024
KS
Krzysztof Strekowski
Chief Executive Officer
Chief Executive Officer
2023 – 2024
VR
Vibeke Røstengen
Deputy Member
Deputy Member
2023 – 2024
JP
Jonas Potyka
Chief Executive Officer
Chief Executive Officer
2024 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
MH
Mikko Henrik Tiitinen
Chairman
2025
MC
Mats Christer Hermansson
Board of Directors
2024
HB
Hege Børringbo
Board of Directors
2023
Former (8)
FR
Frank Roger Los
Board of Directors
2023 – 2024
AS
Asbjørn Solberg-Eriksen
Board of Directors
2020 – 2021
SC
Siw-Hege Christiansen
Board of Directors
2023 – 2024
MM
Marc-Alexander Mahl
Chairman
2023 – 2024
MR
Morten Rakkenes
Board of Directors
2024 – 2024
TJ
Tone Janikke Gummesen Thon
Board of Directors
2023 – 2024
BD
Bernard Dierickx
Board of Directors
2024 – 2024
TN
Tanja Nicole Greve
Chairman
2021 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Fresenius Kabi Sverige Ab
Company
100%
100%
2023
Fresenius Kabi Sverige Ab
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on FRESENIUS KABI NORGE AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network